Degradation of Tyrosine Phosphatase PTPN3 (PTPH1) by Association with Oncogenic HumanPapillomavirus E6 Proteins
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Oncoproteins from DNA tumor viruses associate with critical cellular proteins to regulate cell proliferation, survival, and differentiation.Human papillomavirus (HPV) E6 oncoproteins have been previously shown to associate with a cellular HECT domain ubiquitin ligase termed E6AP (UBE3A). Here we show that the E6-E6AP complex associates with and targets the degradation of the protein tyrosine phosphatase PTPN3 (PTPH1) in vitro and in living cells. PTPN3 is a membrane-associated tyrosine phosphatase with FERM, PDZ, and PTP domains previously implicated in regulating tyrosine phosphorylation of growth factor receptors and p97 VCP (valosin-containing protein, termed Cdc48 in Saccharomyces cerevisiae ) and is mutated in a subset of colon cancers. Degradation of PTPN3 by E6 requires E6AP, the proteasome, and an interaction between the carboxy terminus of E6 and the PDZ domain of PTPN3. In transduced keratinocytes, E6 confers reduced growth factor requirements, a function that requires the PDZ ligand of E6 and that can in part be replicated by inhibiting the expression of PTPN3. This report demonstrates the potential of E6 to regulate phosphotyrosine metabolism through the targeted degradation of a tyrosine phosphatase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Rules for Making Human Tumor Cells
Hahn, W. C., & Weinberg, R. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra021902 · Cited by 951 · cited 1×
“One hallmark of the progression from normal to malignant cells is a reduced requirement for exogenously supplied growth factors (15).”
BackgroundHuibregtse, J. M., Scheffner, M., & Howley, P. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04990.x · Cited by 879 · cited 1×
“16E6 interacts with an LXXLL peptide sequence found on the cellular E3 ubiquitin ligase E6AP and together with E6AP binds to the p53 tumor suppressor protein (17), resulting in its ubiquitin-mediated degradation by the proteasome.”
Background
Cited by
Narisawa‐Saito, M., & Kiyono, T. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00546.x · Cited by 528
Papillomavirus E6 oncoproteins
Vande Pol, S. B., & Klingelhutz, A. J. (2013) · Virology · doi:10.1016/j.virol.2013.04.026 · Cited by 346
Self-citationHowie, H. L., Katzenellenbogen, R. A., & Galloway, D. A. (2009) · Virology · doi:10.1016/j.virol.2008.11.017 · Cited by 332
Oncogenic activities of human papillomaviruses
McLaughlin-Drubin, M. E., & Münger, K. (2009) · Virus Research · doi:10.1016/j.virusres.2009.06.008 · Cited by 321
White, E. A., Kramer, R. E., Tan, M. J. A., Hayes, S. D., Harper, J. W., & Howley, P. M. (2012) · Journal of Virology · doi:10.1128/jvi.02172-12 · Cited by 198
“Each of these interactions had been previously reported for at least one high-risk HPV E6 (30, 31, 47, 65).”
BackgroundEmerging theme: cellular PDZ proteins as common targets of pathogenic viruses
Javier, R. T., & Rice, A. P. (2011) · Journal of Virology · doi:10.1128/jvi.05410-11 · Cited by 198
“High-risk HPV E6 proteins also bind to and promote degradation of two different nonreceptor FERM domain-containing protein tyrosine phosphatases, PTPN3/PTPH1 (47, 118) and PTPN13 (105).”
BackgroundHuman papillomaviruses, cervical cancer and cell polarity
Thomas, M., Narayan, N., Pim, D., Tomaić, V, Massimi, P., Nagasaka, K., Kranjec, C., Gammoh, N., & Banks, L. (2008) · Oncogene · doi:10.1038/onc.2008.351 · Cited by 163
Zanier, K., ould M'hamed ould Sidi, A., Boulade-Ladame, C., Rybin, V., Chappelle, A., Atkinson, A., Kieffer, B., & Travé, G. (2012) · Structure · doi:10.1016/j.str.2012.02.001 · Cited by 125
Jha, S., Vande Pol, S., Banerjee, N. S., Dutta, A. B., Chow, L. T., & Dutta, A. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.020 · Cited by 120
Self-citationPDZ domains: The building blocks regulating tumorigenesis
Subbaiah, V. K., Kranjec, C., Thomas, M., & Banks, L. (2011) · Biochemical Journal · doi:10.1042/bj20110903 · Cited by 106
Human papillomaviruses and the specificity of PDZ domain targeting
Pim, D., Bergant, M., Boon, S. S., Ganti, K., Kranjec, C., Massimi, P., Subbaiah, V. K., Thomas, M., Tomaić, V., & Banks, L. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08709.x · Cited by 94
Viral Interactions with PDZ Domain-Containing Proteins—An Oncogenic Trait?
James, C., & Roberts, S. (2016) · Pathogens · doi:10.3390/pathogens5010008 · Cited by 83
Spangle, J. M., & Munger, K. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003237 · Cited by 76
Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexes
Nguyen, C. L., & Münger, K. (2008) · Virology · doi:10.1016/j.virol.2008.07.017 · Cited by 48
Yoshimatsu, Y., Nakahara, T., Tanaka, K., Inagawa, Y., Narisawa‐Saito, M., Yugawa, T., Ohno, S., Fujita, M., Nakagama, H., & Kiyono, T. (2017) · Cancer Science · doi:10.1111/cas.13264 · Cited by 44
E3 ubiquitin ligases and human papillomavirus-induced carcinogenesis
Lou, Z., & Wang, S. (2014) · Journal of International Medical Research · doi:10.1177/0300060513506655 · Cited by 22
Marsh, E. K., Delury, C. P., Davies, N. J., Weston, C. J., Miah, M. A. L., Banks, L., Parish, J. L., Higgs, M. R., & Roberts, S. (2017) · Oncotarget · doi:10.18632/oncotarget.14469 · Cited by 16
Metadata
- Authors
- Jing, M., Bohl, J., Brimer, N., Kinter, M., & Vande Pol, S. B.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2007-03
- Volume
- 81
- Issue
- 5
- Pages
- 2231-2239
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2171213086
- Cited by
- 105
- References
- 3
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.